Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Board changes

19 Mar 2020 07:00

RNS Number : 7041G
PZ CUSSONS PLC
19 March 2020
 

19 March 2020

 

PZ Cussons Plc

 

Board changes

 

PZ Cussons plc ("PZ Cussons" or the "Company"), a leading consumer products group, has announced today the appointment of a new Chief Executive Officer with effect from 1 May.

 

The Company also announces the appointment of Jeremy Townsend as a Non-executive Director with effect from 1 April. Jeremy is currently Chief Financial Officer of Rentokil Initial plc but is due to retire later this year. An experienced FTSE100 finance director, he was previously Group Finance Director of Mitchells & Butlers and held senior finance positions at Sainsbury's after starting his career with Ernst & Young. He is also a former Accounting Council Member of the Financial Reporting Council. Since 2017, he has been a Non-executive Director and Chair of the Audit Committee for Galliford Try plc. On appointment, Jeremy will join the Audit & Risk Committee.

 

Jez Maiden, who has served the Board as a Non-executive Director since 2016, has advised the Company of his intention to step down on 31 May 2020. He will be succeeded as Chair of the Audit & Risk Committee by Jeremy Townsend.

 

Caroline Silver, Chair of PZ Cussons, said:

 

"We are pleased to welcome Jeremy Townsend to the Board. He has been part of a highly successful executive team at Rentokil Initial and is also an experienced Non-executive Director and Audit Chair. His appointment will further strengthen the Board and he will be an able replacement for Jez Maiden as Chair of the Audit & Risk Committee when he retires later this year.

 

I would also like to thank Jez for his years of service to the Board and for the significant contribution which he has made to the effective operation of the Audit & Risk Committee."

 

There are no further details in respect of Jeremy Townsend requiring disclosure under Listing Rules 9.6.13(2) to 9.6.13(6) inclusive.

 

- Ends -

 

For further information contact:

 

PZ Cussons Plc

Alan Bergin, Interim Chief Financial Officer

 

0161 435 1027

Instinctif Partners

Tim Linacre

Guy Scarborough

0207 457 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADZGMFNRFGGZM
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.